Gujarat FDCA Registers 5 Lakhs Product Licenses, 4,880 Mfg Licences Through DMLA Software

Mumbai : The Gujarat Food and Drug Control Administration (FDCA) has been able to register a total of five lakh product licenses and 4,349 manufacturing licenses through its first-of -its kind online platform –drug manufacturing license application (DMLA) software in the country.

As per the data on manufacturing licenses, there are 3, 349 allopathic units, 867 ayurvedic units, 665 cosmetics units and 9 homeopathic units, the data of which is available online.

Besides this, Gujarat today boasts of over 700 plus WHO-GMP units and 130 US FDA approved drug manufacturing units in the country. Gujarat also has the distinction of having 28 per cent of drug exports to developed markets including the US.

The Gujarat pharmaceutical industry is also upbeat as around 900 out of 1,100 plants had started operations in the state despite lockdown. Most of these plants produce formulations.

DMLA enables regulators to deliver efficient paperless services on time for granting product licenses for APIs, single ingredients and formulations under the allopathic segment.

Under this online programme, all the manufacturers under the allopathic segment should apply for product license in the state through online only. Gujarat FDCA’s DMLA also approves technical person’s details, company profile, certificate issue, inspection, sampling report and fresh firm registration, apart from issuing fresh license, renewal of licenses and additional product permission.

It generates instant information on total number of product licenses granted on real time basis thereby offering easy access to the availability of medicines in stock along with all the details of the manufacturers.

Gujarat FDCA Commissioner Dr H G Koshia said, “Gujarat FDCA has also been able to register 41386 wholesale and retail licensees online till date in a time bound manner through online Extended Licensing Node (XLN) system set up in the state in 2007.”

  • Related Posts

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    Lilly takes 6 companies to court for selling retatrutide knockoffs

    FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

    FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch